ProAxsis Transitions to Independent Growth Company to Advance Respiratory Research
A new fundraise will support commercial scale-up and the development of biomarker technology for respiratory disease drug development.
Category: Industry & Regulatory News
Industry & Regulatory News
Latest
Industry & Regulatory News
Latest
HHS Ends COVID-19 Emergency Use Authorizations
HHS secretary Robert F Kennedy, Jr signed determinations to end COVID-19 emergency use authorizations for drugs, biological products, and medical devices because the emergency circumstances no longer exist.
Industry & Regulatory News
Latest
FDA Authorizes Flavored Zyn Nicotine Pouches Despite Youth Risks
The FDA authorized 20 Zyn nicotine pouches, including 10 flavored products, despite concerns from health experts over increased youth use.
Association News
Latest
American Thoracic Society Appoints New President
Michelle Ng Gong succeeds Raed Dweik as president of the American Thoracic Society.
Business News
Latest
ENA Respiratory Secures Two US Patents for COPD Therapy
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
FDA Approvals
Latest
FDA Approves Benralizumab for Hypereosinophilic Syndrome
Benralizumab (Fasenra) is now indicated to reduce the risk of flare ups for adult and pediatric patients with hypereosinophilic syndrome.
Recalls & Advisories
Latest
FDA: Urgent Correction for Baxter Volara System
Baxter issued an Urgent Medical Device Correction notice for all Volara System patient circuits to be corrected prior to continued use, according to an FDA alert.